Specialty Council on Infectious Diseases Pharmacy

2020 Members

Kathryn Dzintars, PharmD, BCPS-AQ ID {Chair}
Dzintars obtained her Doctor of Pharmacy from the University of Pittsburgh School of Pharmacy. She completed her pharmacy practice residency at University Health System and specialty residency in infectious diseases at the South Texas Veterans Health Care System, both in conjunction with the University of Texas Health Science Center, San Antonio, TX. She is currently a clinical pharmacy specialist in infectious diseases and antimicrobial stewardship at The Johns Hopkins Hospital. Her current professional interests include antimicrobial stewardship, antifungal therapy, and gram-negative resistance. 

Elizabeth Leung, PharmD, MSCI, BCPS-AQ ID {Vice Chair}
Leung is a Clinical Pharmacy Specialist in Infectious Diseases/Antimicrobial. Stewardship, and the co-lead of the Antimicrobial Stewardship Program (ASP) at St. Michael’s Hospital, a teaching hospital of the University of Toronto. She completed a pharmacy practice residency at UCSF, then completed two further years of residency in Chicago, where she specialized in both infectious diseases and critical care (Northwestern University, Rush University, Midwestern University Chicago College of Pharmacy). She received her PharmD from MCPHS, and completed a Masters of Clinical Investigation (MSCI) at Northwestern University.  Her interests include antimicrobial stewardship, optimizing PK/PD for multi-drug resistant organisms, and enhancing antibiograms for clinical use.

Russell Benefield, PharmD, BCPS-AQ ID
Benefield is a Clinical Pharmacy Specialist in Infectious Diseases and Program Director for the PGY-2 infectious diseases pharmacy residency at the University of Utah Health in Salt Lake City, UT. He received his BS from the University of Washington and PharmD from Washington State University. Dr. Benefield completed a PGY-1 residency at the University of Oklahoma College of Pharmacy/OU Medical Center, and PGY-2 residency in infectious diseases at the Oklahoma City VA.  His primary clinical practice focus is in immunocompromised infectious diseases.

Curtis Collins, PharmD, MS, BCPS-AQ ID, FASHP
CollinsCollins is a Clinical Pharmacy Specialist in Infectious Diseases at St. Joseph Mercy Health System in Ann Arbor, MI. He received his Doctor of Pharmacy from Drake University, and completed a PGY-2 residency and obtained a MS in Health-Systems Pharmacy Administration from The Ohio State University. His professional interests include antimicrobial stewardship, quality improvement, and pharmacoeconomics.

Jason Gallagher, PharmD, BCPS
Gallagher is Clinical Professor at Temple University School of Pharmacy and Clinical Pharmacy Specialist in Infectious Diseases at Temple University Hospital. He is the Director of the PGY-2 residency in infectious diseases pharmacy at Temple. Gallagher received his Doctor of Pharmacy from Rutgers University. He completed residency programs in Pharmacy Practice at Virginia Commonwealth University-Medical College of Virginia and in Infectious Diseases in the Immunocompromised Host at Duke University. Dr. Gallagher is also a past President of the Society of Infectious Diseases Pharmacists and the Mid-Atlantic College of Clinical Pharmacy. He has co-authored four editions of Antibiotics Simplified and is a Fellow of the American College of Clinical Pharmacy and the Infectious Diseases Society of America.

Jennifer Girotto PharmD, BCPPS, BCIDP
IFD_GirottoGirotto is a Clinical Associate Professor of Pharmacy Practice and Pediatrics at the University of Connecticut. Her clinical practice site is at Connecticut Children’s Medical Center, where she is the Co-Director of the antimicrobial stewardship program and Program Director of the PGY2 infectious diseases pharmacy residency program. She completed her Doctor of Pharmacy at the University of Connecticut and completed an ASHP accredited specialty residency in pediatrics at Children’s Hospital in Boston. Her interests include optimizing PK/PD in pediatric patients, antimicrobial stewardship and immunizations.

Kathryn G. Merkel, PharmD, BCPS, BCPPS, BCIDP
IFD_MerkelMerkel is a Clinical Pharmacy Manager at St. David’s South Austin Medical Center in Austin, Texas practicing previously as a Pediatric Infectious Diseases Clinical Pharmacy Specialist at Dell Children’s Medical Center for six years. She earned her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill, and then went on to complete a PGY-1 pharmacy practice residency and PGY-2 infectious diseases residency at Indiana University Health. Her interests include antimicrobial stewardship, quality/process improvement, and education of the public on antimicrobial resistance.

Steve Mok, PharmD, BCIDP, BCPS
Steve MokMok is Clinical Program Manager, Clinical Surveillance and Compliance and Program Director of the Fellowship in Health Outcomes and Analytics at Wolters Kluwer, Health. He received his Doctor of Pharmacy from the University of Pittsburgh and completed his Infectious Diseases residency at the Bay Pines VA Healthcare System in St Petersburg, Florida. His current practice focuses on using advanced technologies such as artificial intelligence and machine learning to identify patients at high risk for epidemiologically significant infection or drug resistant organisms and helping pharmacists optimize antimicrobial stewardship practices with real time clinical analytics tools.

Radhika S. Polisetty, PharmD, BCIDP, AAHIVP, BCPS-AQ ID
Radhika PolisettyPolisetty is an Associate Professor in the Department of Pharmacy Practice at Midwestern University Chicago College of Pharmacy and Clinical Specialist, Infectious Diseases at Northwestern Medicine Central DuPage Hospital in Winfield, IL. Dr. Polisetty is a graduate of the University Of Kentucky College of Pharmacy and went on to complete a PGY1 Pharmacy Practice Residency and a PGY 2 Infectious Diseases Residency at the University of Pittsburgh Medical Center in Pittsburgh, PA. Dr. Polisetty’s primary area of focus is managing an Antibiotic Stewardship Program and conduct research optimizing antimicrobial utilization in a community setting.